Skip to content

Effects of BBT Versus Diaphragmatic Breathing on Exercise Capacity and Quality of Life in Patients With COPD

Effects of BBT Versus Diaphragmatic Breathing on Exercise Capacity and Quality of Life in Patients With COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05947227
Enrollment
48
Registered
2023-07-17
Start date
2023-06-15
Completion date
2023-11-20
Last updated
2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breathing Technique

Keywords

Chronic obstructive pulmonary disease/COPD, Diaphragmatic breathing technique

Brief summary

Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks

Detailed description

A randomized clinical trial will be conducted at Gulab Devi Hospital, Lahore through convenience sampling technique on 48 patients which will be allocated through simple random sampling through sealed enveloped into group A and group B. Pre-treatment values of patients exercise capacity will be recorded by 6MWT/6MWD- 6 minute walk test/ 6 minutes' walk distance and patients quality of life through St George respiratory questionnaire as primary outcomes while oxygen saturation, heart rate will be measured by pulse oximtery during 6MWT as secondary outcomes. Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks. Data will be analyzed using SPSS software version 25.After assessing normality of data by Shapiro-Wilk test , it will be decidedeither parametric or non-parametric test will be used.

Interventions

Group A : will be treated with manual chest physiotherapy & Buteyko Breathing exercise

OTHERDiaphragmatic breathing technique.

Group B : will be treated with manual chest physiotherapy & Diaphragmatic Breathing Treatment evaluation will be done after 8 weeks through 6MWT & St George respiratory Questionnaire. Patients will perform technique 5 times a weeks for 8 weeks

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks.

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age group : 40-65 years * Both males and females * Clinical diagnosis of COPD confirmed by smoking history and PFT airflow * Patients taking their regular medications e.g bronchodilator

Exclusion criteria

* Restrictive lung disease * Pneumothorax * Resting O2 saturation \<90% with room air breathing * Recent exacerbations * Patients with active viral or bacterial infection * Abdominal or thoracic surgery (\<3months ago) * Cardiologic conditions (\<6months ago e.g Myocardial infarction or unstable angina * Intubated Patients * Orthopedic or urogenital conditions * Neurological disorders limiting cognition & mobility

Design outcomes

Primary

MeasureTime frameDescription
6 Minute Walk Distance4 weeks.Distance will be measured in meter through 6 minute walk test.

Secondary

MeasureTime frameDescription
St George Respiratory Questionnaire for quality of life :4 weeks.St George Respiratory Questionnaire/SGRQ is a well established disease specific for health status in asthma and COPD (26).A total three component scores are provided , symptoms (8 items) , activity (16 items) and impacts (26 items), 50 items vary as likert type scale and dichotomus (true/false). In the symptom component , patients are instructed to recall their symptoms in a specific time frame of 1 month , 3 months or 1 year. Other items are not time specific.Scores ranged from 0 ( no impairment ) to 100 ( worst health status)

Other

MeasureTime frameDescription
oxygen saturation4 weeksOxygen saturation will be measured through pulse oximeter.
heart rate4 weeksPulse rate will be measured through pulse oximeter which will be consider as heart rate of the patient.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026